ArticleClinical rheumatology2022

Safety of JAK inhibitor use in patients with rheumatoid arthritis who developed herpes zoster after receiving JAK inhibitors.

Wonho Choi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.